Welcome to my podcast. I am Doctor Warrick Bishop, and I want to help you to live as well as possible for as long as possible. I’m a practising cardiologist, best-selling author, keynote speaker, and the creator of The Healthy Heart Network. I have over 20 years as a specialist cardiologist and a private practice of over 10,000 patients.

Podcast Summary: EP402 - Remote Monitoring Menopause and Much More

Introduction: Dr. Auric Bishop, a cardiologist and CEO of the Healthy Heart Network, hosts this episode featuring Mark Goddard, a registered nurse and Vice President of Clinical Services for Infobionic, a US-based remote cardiac monitoring company. The episode explores advances in remote cardiac device monitoring technology and discusses the significant cardiovascular impacts of hormonal changes, particularly menopause, in women's health.

Key Takeaways:

• Remote monitoring technology for implantable cardiac devices (pacemakers and defibrillators) has revolutionized patient care by providing real-time data instead of waiting for quarterly office visits, allowing immediate detection of dangerous arrhythmias.

• Infobionic's wearable monitoring devices allow patients to wear portable ECG monitors for 1-30 days with near real-time transmission, dramatically improving the odds of capturing infrequent cardiac events compared to traditional 24-hour Holter monitors.

• Tiny injectable cardiac monitoring devices smaller than a finger can now be implanted under the skin to continuously record heart rhythm for up to three years, providing long-term monitoring data when initial wearable monitoring doesn't detect issues.

• Estrogen is cardioprotective, and women who experience menopause lose this natural protection, significantly increasing their cardiovascular risk, particularly those with early menopause.

• Early menopause is a marker of increased future cardiac risk and requires baseline cardiological assessment and ongoing management to prevent cardiovascular complications.

• Hormone replacement therapy timing is critical—initiated soon after menopause may provide cardiac benefits, but starting 10+ years after menopause can be detrimental, requiring careful clinician guidance.

• As people age beyond 50, the prevalence of arrhythmias including atrial fibrillation and premature beats increases significantly in both men and women, making baseline cardiovascular screening essential.

• Infobionic is developing AI algorithms partnered with Mayo Clinic to predictively identify patients at risk for atrial fibrillation before it occurs, moving toward preventive rather than reactive cardiology.

• FDA-approved AI analysis can now assess ejection fraction (heart pumping function) from wearable ECG devices, with a billing code established and deployment expected within six months.

• Preventive cardiology focuses on identifying high-risk patients through chamber size assessment, blood pressure history, weight, and age to proactively manage cardiac risk before symptomatic events occur.